OncoCyte Corp (OCX)
2.69
-0.14
(-4.95%)
USD |
NASDAQ |
May 28, 16:00
2.69
0.00 (0.00%)
After-Hours: 16:11
OncoCyte Total Long Term Debt (Quarterly): 0.00 for March 31, 2024
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.574M |
| March 31, 2022 | 0.945M |
| Date | Value |
|---|---|
| December 31, 2021 | 1.313M |
| September 30, 2021 | 1.678M |
| June 30, 2021 | 2.041M |
| March 31, 2021 | 3.541M |
| December 31, 2020 | 3.898M |
| September 30, 2020 | 4.126M |
| June 30, 2020 | 4.104M |
| March 31, 2020 | 3.065M |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
Sep 2022
4.126M
Maximum
Sep 2020
1.487M
Average
0.945M
Median
Mar 2022
Total Long Term Debt (Quarterly) Benchmarks
| Fonar Corp | 0.126M |
| XWELL Inc | 0.00 |
| ProPhase Labs Inc | 12.68M |
| Applied DNA Sciences Inc | 0.00 |
| Veracyte Inc | 0.00 |